Board Member
Dario Neri, Ph.D
CEO & CSO
Co-founder
Dario Neri is Co-founder, CEO, CSO and President of the Scientific Advisory Board of Philogen. He graduated in Chemistry at the Scuola Normale Superiore in Pisa and obtained his Ph.D. in Chemistry from ETH Zurich, under the supervision of Prof. Kurt Wüthrich, winner of the Nobel Prize for Chemistry in 2002. For his dissertation, he was awarded the Silver Medal of ETH. After a 5 years post-doctoral research position in the lab of 2018 Chemistry Nobel Price Winner Sir Gregory Winter at the Cambridge Centre of Protein Engineering in Cambridge, UK, he returned to ETH Zurich in 1996 as Assistant Professor in Molecular Structure Biology. From 1999 he has been a Professor of Biomacromolecules in the department of Chemistry and Applied Biosciences at ETH Zurich, before he permanently joined Philogen in 2020.
Prof. Neri is recipient of numerous awards, including the ISOBM Abbott Prize 2000, of the Amgen-Dompe' Biotec Award 2000, the Prous Award 2006 of the European Federation of Medicinal Chemistry, of the Phoenix Prize 2014, of the Paul Harris Award 2022, and of the Pratesi Medal of the Italian Chemical Society 2023. He is author of more than 500 publications in international scientific journals
Chairman
Duccio Neri
Executive Chairman
Co-founder
Duccio Neri is Co-founder and Chairman of Philogen. He graduated in Business Administration and Economics at the Bocconi University in Milan, specializing in Corporate Finance. Dr. Neri has a special expertise in Financial Consulting, Tax and Audit Advice and Business Administration and is a Partner of the “Studio Neri – Tanini”. He was a representative of the Italian Government in the Board of the University of Siena and an auditor of the Cassa di Risparmio di San Miniato (CRSM) S.p.A., MPS Banca Verde S.p.A., MPS Fiduciaria S.p.A., MPS Professional S.p.A., and of several other firms.
Board Member
Laura Baldi
Chief Financial Officer
Laura Baldi graduated from the University of Siena in Economic and Banking Sciences. She was group controller at the general management of ENEL S.p.A. from 1997 to 1999. Mrs. Baldi has worked as a freelance consultant in management and tax matters for several corporations and she is a chartered accountant and auditor. Since 2003 Laura Baldi has worked for Philogen with increasing roles and responsibilities in the AFC area. She is currently Chief Financial Officer of the group and has more than ten years of experience in corporate secretariat functions.
Head of Research
Samuele Cazzamalli
Head of Research
Dr. Samuele Cazzamalli studied Medicinal Chemistry at Universitá degli Studi di Milano, where he graduated with a thesis on the development of novel techniques for the application of biocatalysts in flow chemistry under the supervision of Prof. Carlo De Micheli. Samuele performed his PhD at ETH Zurich in the group of Professor Dario Neri with a focus on non-internalizing antibody- and small molecule-drug conjugates for the treatment of cancer. Samuele currently heads research at Philochem. He is the recipient of the 2024 EFMC Prize for Young Medicinal Chemist in Industry.
The updated list of peer-reviewed publications by Dr. Cazzamalli can be found https://scholar.google.com/citations?user=SjyqgywAAAAJ&hl=it&oi=ao
Board Member
Emanuele Puca, Ph.D.
Business Development and Operations
Emanuele Puca is responsible for Business Development, Investor Relations and Operations at the Philogen group. He graduated in Medicinal Chemistry at La Sapienza University and performed his Ph.D. studies at ETH Zürich focusing on the generation of antibody-cytokine fusion proteins for the treatment of extracranial and brain tumors. Dr. Puca is author of several peer-reviewed publications in international scientific journals and is recipient of the Swiss Brain Tumor Foundation 2021 and of the Pfizer Research Prize 2022.